New funding for early diagnosis research using platelets
30 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.
Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis
16 February 2021
MRC WIMM researchers have revealed a population of immune cells that travel to the brain in patients with multiple sclerosis causing disease. They demonstrate how to trap these cells in the blood, meaning they can be targeted to prevent disease progression.
New sequencing methods for distinguishing DNA modifications
15 February 2021
Expansion of suite of bisulphite-free DNA modification sequencing methods to specifically and directly detect each of the four modifications made to the DNA base cytosine.
MRC WIMM's Noemi Roy among seven projects awarded Public Engagement Seed Funding 2020-21
3 February 2021
Dr Noemi Roy has received funding in the 2020-21 round of the Public Engagement with Research Seed Fund as one of seven projects for innovative work to engage the public with medical research.
New study maps the development of the human intestine
20 January 2021
Researchers in the Simmons lab chart the embryonic origins and appearance of diverse intestinal cellular compartments, with important implications for intestinal diseases.
MRC HIU appoints new Director
6 January 2021
We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.
Research unpicks why immune responses decrease with age
27 November 2020
Study reveals what happens to blood cell production during the ageing process, which could help identify new therapeutic targets.
Study uncovers how low blood iron diminishes immune response
25 November 2020
The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.
Study finds new human blood disorder
18 November 2020
The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells
Interferon-b trial shows positive results
16 November 2020
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients. MRC HIU's Professor Ling-Pei Ho is one of the main co-authors on the paper.